 |
|
|
|
 |
- A Phase I Study of Intrathecal Radioimmunotherapy Using 131I-8H9 for Central Nervous System/Leptomeningeal Cancers
Kramer, Kim, MD
[Protocol 03-133]
- A Phase II Study of Conformal Radiotherapy in Patients with Low-Grade Gliomas
Dunkel, Ira, MD
[Protocol 07-049]
- A Phase II Study of Intrathecal I131-3F8 in Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
Kramer, Kim, MD
[Protocol 05-122]
- A Phase II Study of Radiation Therapy, Cetuximab, and Irinotecan in Children and Young Adults with Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas
Dunkel, Ira, MD
[Protocol 09-014]
- A Phase III Study Assessing Carboplatin and/or Isotretinoin plus Radiation in Patients with Supratentorial Primitive Neuroectodermal Tumor or High-Risk Medulloblastoma
Gilheeney, Stephen, MD
[Protocol 07-174]
- A Phase III Study of Intensive Induction Chemotherapy with or without Methotrexate Followed by Consolidation Therapy with Stem Cell Rescue in Young Children Newly Diagnosed with Supratentorial PNET or High-Risk Medulloblastoma
Gilheeney, Stephen, MD
[Protocol 07-170]
- A Study of Cilengitide (EMD 121974) in Recurrent or Progressive and Refractory Childhood High-Grade Glioma
Gilheeney, Stephen, MD
[Protocol 08-143]
- GLIOGENE: Genetic Epidemiology of Glioma International Consortium
Bernstein, Jonine, PhD
[Protocol 07-137]
- Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
Becher, Oren, MD
[Protocol 08-091]
- Phase II Study of Nimotuzumab (TheraCIM®) in Pediatric Patients with Recurrent Diffuse Intrinsic Pontine Glioma
Trippett, Tanya, MD
[Protocol 08-034]
- Treatment of Atypical Teratoid/Rhabdoid Tumors of the Central Nervous System with Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation
Dunkel, Ira, MD
[Protocol 09-070]
|
|
|
|
|
